Drug Shortage Report for ALENDRONATE

Last updated on 2022-07-06 History
Report ID 153051
Drug Identification Number 02352966
Brand name ALENDRONATE
Common or Proper name ALENDRONATE
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 50
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-19
Estimated end date 2022-06-30
Actual end date 2022-06-30
Shortage status Resolved
Updated date 2022-07-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-19 English Compare
v2 2022-01-19 French Compare
v3 2022-01-20 English Compare
v4 2022-05-02 English Compare
v5 2022-05-02 French Compare
v6 2022-05-24 English Compare
v7 2022-05-24 French Compare
v8 2022-06-20 English Compare
v9 2022-06-20 French Compare
v10 2022-07-06 English Compare
v11 2022-07-06 French Compare

Showing 1 to 11 of 11